Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde, UK
Andrew graduated from Aberdeen in 1989 and trained in General Medicine/ infectious diseases in Dundee and Papua New Guinea. He was appointed consultant physician in Glasgow in 2000 and he is an Honorary Clinical Associate Professor in the University of Glasgow. He established and leads the NHS Greater Glasgow and Clyde OPAT service and Antimicrobial Management Team. He Chairs the Scottish Antimicrobial Prescribing Group and co-leads the BSAC OPAT initiative. He has >160 peer reviewed publications and has co-produced the BSAC OPAT MOOC on future learn.
B. Braun is one of the world’s leading providers and manufacturers of healthcare solutions today.
Every service that B. Braun provides incorporates the entirety of our knowledge and skills, the company’s deep understanding of users’ needs, and extensive expertise since 1839.
With its constantly growing portfolio of effective medical care solutions, B. Braun makes a substantial contribution towards protecting and improving people’s health.
By offering supplementary services and consulting, B. Braun is a system supplier that develops the best solution for patients in close partnership with our customers, making a
significant contribution to medical advancements.
System partnerships, relationships and earnings are the core themes which are to be pursued in all divisions and regions, with the support of the centralised units and departments.
The goal is to grow together in order to ensure that our company will be able to operate independently in the current strategic period. This will allow us in the future to continue making
a contribution to protecting and improving the health of people all over the world.
BIOPATCH® is an antimicrobial sponge dressing providing 7-day release of Chlorhexidine Gluconate. It is indicated to reduce local infections, catheter-related blood stream infections (CRBSI), and skin colonization of microorganisms commonly related to CRBSI from vascular and non-vascular percutaneous devices. BIOPATCH® can help improve patient outcomes, reduce hospital costs and reduce CRBSIs.
Horizon Strategic Partners (HSP) was established in 2008 to provide IT Consultancy Services to the Department of Health. Since then it has developed a range of mobile healthcare solutions that are used in over 50% of all UK Acute Hospital Trusts.
HSP has worked with the BSAC over a number of years on various IT projects, such as the development of the OPAT National Outcomes Registry which provides the most comprehensive overview of OPAT service provision in the UK. Recently HSP has worked with PHE to develop a Point Prevalence Survey (PPS) System that was used on a national basis to collect data for the 2016 ECDC survey of healthcare-associated infections and antimicrobial use in acute care hospitals.
In 2017 HSP took over the IPR and development of the OPAT Patient Management System (PMS), with an upgraded system being launched in 2018.